| LncRNA NR2F1-AS1 as a potential biomarker for prognosis in cancer patients: meta and bioinformatics analysis. | LncRNA NR2F1-AS1 as a potential biomarker for prognosis in cancer patients: meta and bioinformatics analysis.
Tang L, Liu QM, Zhang S, Zhou J. | 01/10/2024 |
| Lnc NR2F1-AS1 Promotes Breast Cancer Metastasis by Targeting the MiR-25-3p/ZEB2 Axis. | Lnc NR2F1-AS1 Promotes Breast Cancer Metastasis by Targeting the MiR-25-3p/ZEB2 Axis.
Zhai D, Zhou Y, Kuang X, Shao F, Zhen T, Lin Y, Wang Q, Shao N., Free PMC Article | 08/19/2023 |
| NR2F1-AS1: A Functional Long Noncoding RNA in Tumorigenesis. | NR2F1-AS1: A Functional Long Noncoding RNA in Tumorigenesis.
Hu J, Peng F, Qiu X, Yang J, Li J, Shen C, Yuan C. | 06/28/2023 |
| A review on the role of NR2F1-AS1 in the development of cancer. | A review on the role of NR2F1-AS1 in the development of cancer.
Ghafouri-Fard S, Khoshbakht T, Hussen BM, Baniahmad A, Taheri M, Samsami M. | 12/17/2022 |
| Hypoxia-induced long noncoding RNA NR2F1-AS1 maintains pancreatic cancer proliferation, migration, and invasion by activating the NR2F1/AKT/mTOR axis. | Hypoxia-induced long noncoding RNA NR2F1-AS1 maintains pancreatic cancer proliferation, migration, and invasion by activating the NR2F1/AKT/mTOR axis.
Liu Y, Chen S, Cai K, Zheng D, Zhu C, Li L, Wang F, He Z, Yu C, Sun C., Free PMC Article | 04/16/2022 |
| The EMT-induced lncRNA NR2F1-AS1 positively modulates NR2F1 expression and drives gastric cancer via miR-29a-3p/VAMP7 axis. | The EMT-induced lncRNA NR2F1-AS1 positively modulates NR2F1 expression and drives gastric cancer via miR-29a-3p/VAMP7 axis.
Li D, Xu M, Wang Z, Huang P, Huang C, Chen Z, Tang G, Zhu X, Cai M, Qin S., Free PMC Article | 04/16/2022 |
| LncRNA nuclear receptor subfamily 2 group F member 1 antisense RNA 1 (NR2F1-AS1) aggravates nucleus pulposus cell apoptosis and extracellular matrix degradation. | LncRNA nuclear receptor subfamily 2 group F member 1 antisense RNA 1 (NR2F1-AS1) aggravates nucleus pulposus cell apoptosis and extracellular matrix degradation.
Du L, Li X, Gao Q, Yuan P, Sun Y, Chen Y, Huang B, Deng Y, Wang B., Free PMC Article | 02/26/2022 |
| STAT3 activates the transcription of lncRNA NR2F1-AS1 to promote the progression of melanoma via regulating the miR-493-5p/GOLM1 axis. | STAT3 activates the transcription of lncRNA NR2F1-AS1 to promote the progression of melanoma via regulating the miR-493-5p/GOLM1 axis.
Bai M, Wu ZZ, Huang YL, Ke J, Xu Q, Wang X. | 01/29/2022 |
| Long non-coding RNA NR2F1-AS1 induces breast cancer lung metastatic dormancy by regulating NR2F1 and DeltaNp63. | Long non-coding RNA NR2F1-AS1 induces breast cancer lung metastatic dormancy by regulating NR2F1 and ΔNp63.
Liu Y, Zhang P, Wu Q, Fang H, Wang Y, Xiao Y, Cong M, Wang T, He Y, Ma C, Tian P, Liang Y, Qin LX, Yang Q, Yang Q, Liao L, Hu G., Free PMC Article | 09/18/2021 |
| LncRNA NR2F1-AS1 Regulates miR-371a-3p/TOB1 Axis to Suppress Proliferation of Colorectal Cancer Cells. | LncRNA NR2F1-AS1 Regulates miR-371a-3p/TOB1 Axis to Suppress Proliferation of Colorectal Cancer Cells.
Wang J, Dong S, Zhang J, Jing D, Wang W, Dong L, Zhao Y. | 08/7/2021 |
| Long noncoding RNA NR2F1AS1 facilitates the osteosarcoma cell malignant phenotype via the miR4855p/miR2185p/BIRC5 axis. | Long non‑coding RNA NR2F1‑AS1 facilitates the osteosarcoma cell malignant phenotype via the miR‑485‑5p/miR‑218‑5p/BIRC5 axis.
Jia G, Wang Y, Yu Y, Li Z, Wang X., Free PMC Article | 07/10/2021 |
| Long non-coding NR2F1-AS1 is associated with tumor recurrence in estrogen receptor-positive breast cancers. | Long non-coding NR2F1-AS1 is associated with tumor recurrence in estrogen receptor-positive breast cancers.
Sanchez Calle A, Yamamoto T, Kawamura Y, Hironaka-Mitsuhashi A, Ono M, Tsuda H, Shimomura A, Tamura K, Takeshita F, Ochiya T, Yamamoto Y., Free PMC Article | 07/10/2021 |
| Long non-coding RNA NR2F1-AS1 promoted neuroblastoma progression through miR-493-5p/TRIM2 axis. | Long non-coding RNA NR2F1-AS1 promoted neuroblastoma progression through miR-493-5p/TRIM2 axis.
Liu L, Zhao H, He HH, Huang J, Xu YY, Li XL, Wu Y, Wang J, Zhu YB. | 07/3/2021 |
| NR2F1-AS1 regulated miR-423-5p/SOX12 to promote proliferation and invasion of papillary thyroid carcinoma. | NR2F1-AS1 regulated miR-423-5p/SOX12 to promote proliferation and invasion of papillary thyroid carcinoma.
Yang C, Liu Z, Chang X, Xu W, Gong J, Chai F, Cui D. | 05/15/2021 |
| lncRNA NR2F1-AS1 promotes breast cancer angiogenesis through activating IGF-1/IGF-1R/ERK pathway. | lncRNA NR2F1-AS1 promotes breast cancer angiogenesis through activating IGF-1/IGF-1R/ERK pathway.
Zhang Q, Li T, Wang Z, Kuang X, Shao N, Lin Y., Free PMC Article | 05/15/2021 |
| LncRNA NR2F1-AS1 promotes proliferation and metastasis of ESCC cells via regulating EMT. | LncRNA NR2F1-AS1 promotes proliferation and metastasis of ESCC cells via regulating EMT.
Ren P, Zhang H, Chang L, Hong XD, Xing L. | 04/3/2021 |
| Results demonstrated that NR2F1-AS1 was highly expressed in EC, which involved in the proliferation and migration of EC cells through downregulation of miR-363 to target SOX4 and regulating PI3K/AKT/GSK-3(beta) pathway. | LncRNA NR2F1-AS1 is involved in the progression of endometrial cancer by sponging miR-363 to target SOX4.
Wang L, Zhao S, Mingxin YU. | 03/28/2020 |
| results conclude that NR2F1-AS1 regulates hepatocellular carcinoma (HCC) oxaliplatin resistance through targeting miR-363-ABCC1 pathway, providing a vital theoretic mechanism and therapeutic target for HCC chemoresistance. | LncRNA NR2F1-AS1 regulates hepatocellular carcinoma oxaliplatin resistance by targeting ABCC1 via miR-363.
Huang H, Chen J, Ding CM, Jin X, Jia ZM, Peng J., Free PMC Article | 11/30/2019 |